V. Georgoulias

发表

Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay.

E. Lianidou, A. Markou, A. Strati, 2011, Clinical chemistry.

Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.

I. Vlachonikolis, D. Mavroudis, V. Georgoulias, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer

E. Lianidou, D. Mavroudis, V. Georgoulias, 2013, British Journal of Cancer.

Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR

D. Mavroudis, E. Lianidou, A. Markou, 2011, BMC Cancer.

Development and validation of a multiplex methylation specific PCR-coupled liquid bead array for liquid biopsy analysis.

E. Lianidou, A. Markou, A. Strati, 2016, Clinica chimica acta; international journal of clinical chemistry.

' s personal copy CST 6 promoter methylation in circulating cell-free DNA of breast cancer patients

G. Sotiropoulou, E. Lianidou, A. Strati, 2013 .

Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine

D. Mavroudis, I. Boukovinas, M. Taron, 2008, British Journal of Cancer.

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

B. Schilling, A. Argiris, T. Whiteside, 2012, Journal of immunological methods.

Metabolism-Related Gene Expression in Circulating Tumor Cells from Patients with Early Stage Non-Small Cell Lung Cancer

E. Lianidou, A. Markou, E. Tsaroucha, 2022, Cancers.

Pharmacokinetic study of docetaxel in intraoperative hyperthermic i.p. chemotherapy for ovarian cancer

H. Rosing, J. Beijnen, D. Tsiftsis, 2003, Anti-cancer drugs.

Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status

N. Tsakountakis, M. Kafousi, E. Stathopoulos, 2005, BMC Women's Health.

Prognostic signi cance of a combined gene expression analysis in EpCAM(+) CTCs in metastatic breast cancer based on a long follow-up

A. Strati, V. Georgoulias, M. Nikolaou, 2020 .

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)

K. Syrigos, K. Syrigos, G. Samonis, 2006, British Journal of Cancer.

CST6 promoter methylation in circulating cell-free DNA of breast cancer patients.

Georgia Sotiropoulou, G. Sotiropoulou, E. Lianidou, 2013, Clinical biochemistry.

SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer

E. Lianidou, I. Balgkouranidou, S. Kakolyris, 2016, Clinical chemistry and laboratory medicine.

SOX17 promoter methylation in circulating tumor cells and matched cell-free DNA isolated from plasma of patients with breast cancer.

E. Lianidou, Evi S Lianidou, Maria Chimonidou, 2013, Clinical chemistry.

DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells.

Georgia Sotiropoulou, G. Sotiropoulou, E. Lianidou, 2011, Clinical chemistry.

Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.

I. Vlachonikolis, M. Perraki, E. Lianidou, 2003, Anticancer research.

PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer

Georgios S. Ioannidis, A. Voutsina, D. Mavroudis, 2014, British Journal of Cancer.

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC

E. Stathopoulos, A. Voutsina, D. Mavroudis, 2008, British Journal of Cancer.

‘Classical’ but not ‘other’ mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer

E. Stathopoulos, A. Voutsina, S. Murray, 2007, British Journal of Cancer.

Kappa opioids and TGFβ1 interact in human endometrial cells

E. Castanas, E. Chatzaki, A. Makrigiannakis, 2000 .

Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer

J. Meyerhardt, M. Tzardi, S. Ogino, 2009, British Journal of Cancer.

Epidemiological Characteristics, EGFR Status and Management Patterns of Advanced Non-small Cell Lung Cancer Patients: The Greek REASON Observational Registry Study

K. Syrigos, K. Zarogoulidis, C. Christodoulou, 2018, AntiCancer Research.

A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples

Lampros Dimitrakopoulos, P. Vorkas, E. Lianidou, 2012, BMC Cancer.

Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer

D. Welch, E. Lianidou, I. Balgkouranidou, 2014, British Journal of Cancer.

Cisplatin-etoposide alternating with topotecan in patients with extensive stage small cell lung cancer (SCLC). A multicenter phase II study.

D. Mavroudis, N. Tzanakis, G. Samonis, 2002, Lung cancer.

Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients.

G. Yousef, S. Kounelis, E. Lianidou, 2016, Clinical chemistry.

Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel as second-line treatment for peritoneal carcinomatosis of gynaecological origin.

D. Tsiftsis, K. Relakis, J. Melissas, 2003, Anticancer research.

Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination.

H. Rosing, J. Beijnen, D. Tsiftsis, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients’ outcome

M. Tzardi, E. Stathopoulos, D. Mavroudis, 2010, British Journal of Cancer.

Indeterminate human immunodeficiency virus type 1 western blot may indicate an abortive infection in some low‐risk blood donors

M. Theodoropoulou, E. Spanakis, P. Fountouli, 1997, Transfusion.

Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study

K. Syrigos, K. Syrigos, G. Samonis, 2005, British Journal of Cancer.

A Comprehensive Molecular Analysis of in Vivo Isolated EpCAM-Positive Circulating Tumor Cells in Breast Cancer.

G. Kallergi, D. Mavroudis, K. Pantel, 2021, Clinical chemistry.

DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells.

G. Sotiropoulou, E. Lianidou, A. Strati, 2011, Clinical chemistry.

Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients.

G. Yousef, S. Kounelis, E. Lianidou, 2016, Clinical chemistry.

Multiplex detection of ten ESR1 mutations and AKT1 E17K in breast cancer using digital PCR

E. Lianidou, V. Georgoulias, D. Stergiopoulou, 2024, The Journal of Liquid Biopsy.

Liquid biopsy for the management of NSCLC patients under osimertinib treatment.

E. Lianidou, V. Georgoulias, Aliki Ntzifa, 2024, Critical reviews in clinical laboratory sciences.